516 related articles for article (PubMed ID: 31900901)
1. The dual role of tumor necrosis factor-alpha (TNF-α) in breast cancer: molecular insights and therapeutic approaches.
Cruceriu D; Baldasici O; Balacescu O; Berindan-Neagoe I
Cell Oncol (Dordr); 2020 Feb; 43(1):1-18. PubMed ID: 31900901
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.
Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A
Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089
[TBL] [Abstract][Full Text] [Related]
3. Basal-like breast cancer engages tumor-supportive macrophages via secreted factors induced by extracellular S100A4.
Prasmickaite L; Tenstad EM; Pettersen S; Jabeen S; Egeland EV; Nord S; Pandya A; Haugen MH; Kristensen VN; Børresen-Dale AL; ; Engebråten O; Maelandsmo GM
Mol Oncol; 2018 Sep; 12(9):1540-1558. PubMed ID: 29741811
[TBL] [Abstract][Full Text] [Related]
4. TNF-α enhances TGF-β-induced endothelial-to-mesenchymal transition via TGF-β signal augmentation.
Yoshimatsu Y; Wakabayashi I; Kimuro S; Takahashi N; Takahashi K; Kobayashi M; Maishi N; Podyma-Inoue KA; Hida K; Miyazono K; Watabe T
Cancer Sci; 2020 Jul; 111(7):2385-2399. PubMed ID: 32385953
[TBL] [Abstract][Full Text] [Related]
5. Neutralization of TNFα in tumor with a novel nanobody potentiates paclitaxel-therapy and inhibits metastasis in breast cancer.
Ji X; Peng Z; Li X; Yan Z; Yang Y; Qiao Z; Liu Y
Cancer Lett; 2017 Feb; 386():24-34. PubMed ID: 27832973
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol Chemosensitizes TNF-β-Induced Survival of 5-FU-Treated Colorectal Cancer Cells.
Buhrmann C; Yazdi M; Popper B; Shayan P; Goel A; Aggarwal BB; Shakibaei M
Nutrients; 2018 Jul; 10(7):. PubMed ID: 30002278
[No Abstract] [Full Text] [Related]
7. Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer.
Liubomirski Y; Lerrer S; Meshel T; Morein D; Rubinstein-Achiasaf L; Sprinzak D; Wiemann S; Körner C; Ehrlich M; Ben-Baruch A
Front Immunol; 2019; 10():804. PubMed ID: 31105691
[TBL] [Abstract][Full Text] [Related]
8. MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer.
Weng YS; Tseng HY; Chen YA; Shen PC; Al Haq AT; Chen LM; Tung YC; Hsu HL
Mol Cancer; 2019 Mar; 18(1):42. PubMed ID: 30885232
[TBL] [Abstract][Full Text] [Related]
9. NLRX1 regulates TNF-α-induced mitochondria-lysosomal crosstalk to maintain the invasive and metastatic potential of breast cancer cells.
Singh K; Roy M; Prajapati P; Lipatova A; Sripada L; Gohel D; Singh A; Mane M; Godbole MM; Chumakov PM; Singh R
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1460-1476. PubMed ID: 30802640
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of etanercept as anti-breast cancer treatment is attenuated by residing macrophages.
Shirmohammadi E; Ebrahimi SS; Farshchi A; Salimi M
BMC Cancer; 2020 Sep; 20(1):836. PubMed ID: 32883235
[TBL] [Abstract][Full Text] [Related]
11. FOXF2 suppresses the FOXC2-mediated epithelial-mesenchymal transition and multidrug resistance of basal-like breast cancer.
Cai J; Tian AX; Wang QS; Kong PZ; Du X; Li XQ; Feng YM
Cancer Lett; 2015 Oct; 367(2):129-37. PubMed ID: 26210254
[TBL] [Abstract][Full Text] [Related]
12. Altered death receptor signaling promotes epithelial-to-mesenchymal transition and acquired chemoresistance.
Antoon JW; Lai R; Struckhoff AP; Nitschke AM; Elliott S; Martin EC; Rhodes LV; Yoon NS; Salvo VA; Shan B; Beckman BS; Nephew KP; Burow ME
Sci Rep; 2012; 2():539. PubMed ID: 22844580
[TBL] [Abstract][Full Text] [Related]
13. Ponicidin inhibits pro-inflammatory cytokine TNF-α-induced epithelial-mesenchymal transition and metastasis of colorectal cancer cells via suppressing the AKT/GSK-3β/Snail pathway.
Zhang Z; Xu J; Liu B; Chen F; Li J; Liu Y; Zhu J; Shen C
Inflammopharmacology; 2019 Jun; 27(3):627-638. PubMed ID: 30244296
[TBL] [Abstract][Full Text] [Related]
14. The role of TNF-α in chordoma progression and inflammatory pathways.
Gulluoglu S; Tuysuz EC; Sahin M; Yaltirik CK; Kuskucu A; Ozkan F; Dalan AB; Sahin F; Ture U; Bayrak OF
Cell Oncol (Dordr); 2019 Oct; 42(5):663-677. PubMed ID: 31175552
[TBL] [Abstract][Full Text] [Related]
15. Combined niclosamide with cisplatin inhibits epithelial-mesenchymal transition and tumor growth in cisplatin-resistant triple-negative breast cancer.
Liu J; Chen X; Ward T; Pegram M; Shen K
Tumour Biol; 2016 Jul; 37(7):9825-35. PubMed ID: 26810188
[TBL] [Abstract][Full Text] [Related]
16. Anti-EMT properties of CoQ0 attributed to PI3K/AKT/NFKB/MMP-9 signaling pathway through ROS-mediated apoptosis.
Yang HL; Thiyagarajan V; Shen PC; Mathew DC; Lin KY; Liao JW; Hseu YC
J Exp Clin Cancer Res; 2019 May; 38(1):186. PubMed ID: 31068208
[TBL] [Abstract][Full Text] [Related]
17. GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer.
Vijay GV; Zhao N; Den Hollander P; Toneff MJ; Joseph R; Pietila M; Taube JH; Sarkar TR; Ramirez-Pena E; Werden SJ; Shariati M; Gao R; Sobieski M; Stephan CC; Sphyris N; Miura N; Davies P; Chang JT; Soundararajan R; Rosen JM; Mani SA
Breast Cancer Res; 2019 Mar; 21(1):37. PubMed ID: 30845991
[TBL] [Abstract][Full Text] [Related]
18. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer cells obtain an osteomimetic feature via epithelial-mesenchymal transition that have undergone BMP2/RUNX2 signaling pathway induction.
Tan CC; Li GX; Tan LD; Du X; Li XQ; He R; Wang QS; Feng YM
Oncotarget; 2016 Nov; 7(48):79688-79705. PubMed ID: 27806311
[TBL] [Abstract][Full Text] [Related]
20. The molecular contribution of TNF-α in the link between obesity and breast cancer.
Weichhaus M; Broom I; Bermano G
Oncol Rep; 2011 Feb; 25(2):477-83. PubMed ID: 21165572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]